Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real‐World Data From 17 Italian Centers
Head & Neck2025Vol. 47(7), pp. 2040–2047
Citations Over TimeTop 10% of 2025 papers
F Caspani, Stefano Cavalieri, Ester Orlandi, Cristiana Bergamini, Carlo Resteghini, Elena Colombo, Arianna Ottini, Imperia Nuzzolese, Salvatore Alfieri, Aurora Mirabile, Alessandra Cassano, Paolo Bossi, Toni Ibrahim, M.C. Cau, Massimo Ghiani, Federica Bertolini, Rossana Ingargiola, Giulia Fontana, Lisa Licitra, Laura D. Locati
Abstract
Lenvatinib confirmed its activity in the real-world population. A higher than expected rate of grade > 3 stomatitis was reported.
Related Papers
- → Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence(2020)28 cited
- → Artificial Intelligence in Healthcare: Real World Data and Patient Voice — Are We Ready for New Realities?(2021)4 cited
- → Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence(2019)2 cited
- → Use of Real-World Data (RWD) and Real-World Evidence (RWE)(2024)
- → RWD14 The Role of Real-World Data and Real-World Evidence in Australia, EU4, and UK(2024)